14-day Premium Trial Subscription Try For FreeTry Free
$4.57
+0.160 (+3.63%)
At Close: May 01, 2024
Forecast Earnings Fundamentals Insider Trading Signals Historical Prices Predictions News Profile

Range Low Price High Price Comment
30 days $4.25 $5.48 Wednesday, 1st May 2024 QURE stock ended at $4.57. This is 3.63% more than the trading day before Tuesday, 30th Apr 2024. During the day the stock fluctuated 6.31% from a day low at $4.36 to a day high of $4.64.
90 days $4.25 $6.85
52 weeks $4.25 $22.48

Historical uniQure N.V. prices

Date Open High Low Close Volume
Jun 14, 2021 $36.01 $36.39 $34.66 $34.89 483 540
Jun 11, 2021 $37.02 $37.39 $35.75 $36.06 315 693
Jun 10, 2021 $36.54 $36.70 $35.79 $36.66 241 585
Jun 09, 2021 $36.93 $37.79 $36.21 $36.54 242 462
Jun 08, 2021 $37.00 $37.47 $35.69 $36.97 410 493
Jun 07, 2021 $35.40 $37.66 $35.11 $37.17 649 898
Jun 04, 2021 $34.99 $35.79 $34.82 $35.32 398 452
Jun 03, 2021 $33.31 $35.26 $33.28 $34.87 341 354
Jun 02, 2021 $34.49 $34.89 $32.81 $33.69 590 765
Jun 01, 2021 $34.72 $35.22 $34.29 $34.56 287 967
May 28, 2021 $34.28 $35.36 $34.28 $34.73 250 635
May 27, 2021 $33.58 $35.28 $33.42 $34.89 466 535
May 26, 2021 $33.05 $33.48 $32.87 $33.23 145 742
May 25, 2021 $33.75 $33.90 $32.97 $32.97 241 844
May 24, 2021 $34.37 $34.75 $33.55 $33.73 188 117
May 21, 2021 $34.63 $34.82 $33.76 $33.95 222 348
May 20, 2021 $32.46 $34.79 $32.46 $34.70 327 413
May 19, 2021 $33.48 $33.48 $32.30 $32.79 218 820
May 18, 2021 $31.95 $32.97 $31.71 $32.57 215 154
May 17, 2021 $31.66 $32.52 $31.47 $31.71 247 998
May 14, 2021 $31.64 $32.64 $31.32 $32.44 313 080
May 13, 2021 $32.14 $32.84 $30.29 $31.70 403 102
May 12, 2021 $32.14 $33.18 $31.75 $31.97 377 653
May 11, 2021 $32.01 $33.54 $31.09 $32.79 396 268
May 10, 2021 $32.13 $32.85 $31.50 $32.25 370 572
Click to get the best stock tips daily for free!

About uniQure N.V.

uniQure N.V. uniQure N.V., a gene therapy company, engages in the development of treatments for patients suffering from genetic and other devastating diseases. Its lead program is Etranacogene dezaparvovec (AMT-061), which is in Phase III HOPE-B pivotal trial for the treatment of hemophilia B. The company also engages in developing AMT-130, a gene therapy that is in Phase I/II clinical study for the treatment of Huntington's disease; AMT-060, which is in Phas... QURE Profile

Golden Star

Ticker Date Change Price
HRB Apr 29 1.00% $47.23
LYG Apr 29 0.391% $2.56
ORA Apr 29 1.95% $64.48
ETSY Apr 26 3.43% $67.43
DHT Apr 24 0.98% $11.28
LPLA Apr 19 1.10% $262.59
MLI Apr 19 7.29% $52.28
PFLT Apr 18 1.33% $11.25
DOOR Apr 18 0.94% $131.39
OCSL Apr 17 0.360% $19.43
Unlock

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT